Akèy › Ensifizans renn › Alabama
Etid klinik pou Ensifizans renn nan Alabama
5 etid pou Ensifizans renn ap chèche patisipan nan sit nan Alabama.
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
- Infirmary Heath, Mobile
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05880537Pivotal Study of the Velocity™ pAVF System
- Trinity Research Group, Dothan
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Huntsville
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 14, 2026 · NCT06749457Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Trinity Research Group, Dothan
Ap rekrite
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.